Avant Brands stock forecast
Avant Brands (1BU) Stock Forecast & Price Target
1BU Analyst Ratings
There are no analyst ratings in the last 3 months.
1BU Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 0.33→EUR 0.35 | sell | 5.05%Upside | Reiterated | 11/05/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | EUR 0.33→EUR 0.37 | hold | 11.15%Upside | Reiterated | 11/05/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | EUR 0.33→EUR 0.36 | hold | 7.34%Upside | Upgraded | 11/05/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 0.34→EUR 0.37 | hold | 11.72%Upside | Reiterated | 11/05/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 0.33→EUR 0.36 | hold | 6.77%Upside | Upgraded | 11/05/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 0.33→EUR 0.36 | hold | 8.86%Upside | Reiterated | 11/05/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | SellReiteratedEUR 0.33→EUR 0.35 | 11/05/26 | 5.05%Upside | ||
| Google Drug Manufacturers - Specialty and GenericTipRanks - Google | HoldReiteratedEUR 0.33→EUR 0.37 | 11/05/26 | 11.15%Upside | ||
| Anthropic Drug Manufacturers - Specialty and GenericTipRanks - Anthropic | HoldUpgradedEUR 0.33→EUR 0.36 | 11/05/26 | 7.34%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiteratedEUR 0.34→EUR 0.37 | 11/05/26 | 11.72%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldUpgradedEUR 0.33→EUR 0.36 | 11/05/26 | 6.77%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiteratedEUR 0.33→EUR 0.36 | 11/05/26 | 8.86%Upside |
Best Analysts Covering Avant Brands
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -9.68% per trade.
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -9.68% per trade.
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -9.68% per trade.
1BU Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 1BU has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1BU average Analyst price target in the past 3 months is ―.
1BU Financial Forecast
1BU Earnings Forecast
Next quarter’s earnings estimate for 1BU is EUR 0.01 with a range of ― to ―. The previous quarter’s EPS was EUR 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
1BU Sales Forecast
Next quarter’s sales forecast for 1BU is EUR 4.62M with a range of ― to ―. The previous quarter’s sales results were EUR 4.62M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
